Sosei to Cease Development of SOU-001, Drug Candidate for Stress Urinary Inconsistence.Tokyo, Japan, May 16, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Japanese biopharmaceutical company Sosei announced on May 15 that it has decided to discontinue dis·con·tin·ue v. dis·con·tin·ued, dis·con·tin·u·ing, dis·con·tin·ues v.tr. 1. To stop doing or providing (something); end or abandon: the development of SOU-001, its proprietary drug candidate for stress urinary inconsistence in·con·sis·tence n. Inconsistency. (SUI Sui (swā), dynasty of China that ruled from 581 to 618. This short-lived dynasty reunified China in 589 after 400 years of division and laid the foundation for further consolidation under the T'ang dynasty. ). Sosei has made the decision because it has faced a difficulty in recruiting test subjects for clinical trials. The company that discovered the agent in 2001 has been conducting phase IIa clinical trials since June 2005. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion